Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to $408.6 million.

  • Fresenius Medical Care AG's Other Non-Current Liabilities rose 578.15% to $408.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.6 million, marking a year-over-year increase of 578.15%. This contributed to the annual value of $399.8 million for FY2024, which is 6455.71% down from last year.
  • Fresenius Medical Care AG's Other Non-Current Liabilities amounted to $408.6 million in Q3 2025, which was up 578.15% from $409.2 million recorded in Q2 2025.
  • Fresenius Medical Care AG's Other Non-Current Liabilities' 5-year high stood at $1.3 billion during Q3 2022, with a 5-year trough of $386.3 million in Q3 2024.
  • Over the past 5 years, Fresenius Medical Care AG's median Other Non-Current Liabilities value was $809.2 million (recorded in 2022), while the average stood at $797.2 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Other Non-Current Liabilities surged by 6631.57% in 2022, and later plummeted by 6885.38% in 2024.
  • Fresenius Medical Care AG's Other Non-Current Liabilities (Quarter) stood at $809.4 million in 2021, then soared by 49.23% to $1.2 billion in 2022, then fell by 6.61% to $1.1 billion in 2023, then plummeted by 64.56% to $399.8 million in 2024, then grew by 2.19% to $408.6 million in 2025.
  • Its last three reported values are $408.6 million in Q3 2025, $409.2 million for Q2 2025, and $399.0 million during Q1 2025.